We will rely on you to help lend your voice and support the biotechnology industry.
Learn more about BIO initiatives to advance the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO CEO & Investor Conference
February 12-13, 2018
BIO IP Counsels Committee Conference
April 11-13, 2018
BIO Industry Analysis Reports
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
July 16 - 19, 2018 | Philadelphia, Pennsylvania
Matt is the Chief Commercial Officer of Ginkgo Bioworks. Prior to his current role, Matt was the President and Head of Strategy at Decision Resources Group (DRG) as well as a private equity investor for IndUS Growth Partners. Before IndUS, Matt worked supporting business development at Palantir Technologies, a leading provider of analytic software solutions. Matt was also the co-founder of a strategic consulting firm focused on expanding the use of early stage and novel healthcare technologies. Early in his career, Matt served as an officer in the United States Marine Corps. Matt completed a degree in History at Dartmouth College and is a graduate of the joint degree program at the Harvard Business School and the Harvard Kennedy School of Government where he was a Zuckerman Fellow.
This speaker's sessions: